
Privacy notice | Accessibility statement | Terms and conditions | Login | Contact |
UK data driving real-world evidence
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 4 March 2021) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 5MB, 224 pages)This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.
“Ischemic Stroke and Transient Ischemic Attack Risk Following Vitamin K Antagonist Cessation in Newly Diagnosed Atrial Fibrillation: A Cohort Study”, J Am Heart Assoc, vol. 9, p. e014376, 2020.
, “Prediction of significant bleeding during vitamin K antagonist treatment for venous thromboembolism in outpatients”, Br J Haematol, 2020.
, “Variation in the Association between Antineoplastic Therapies and Venous Thromboembolism in Patients with Active Cancer”, Thromb Haemost, vol. 120, pp. 847-856, 2020.
, “Incidence of Lyme disease in the UK: a population-based cohort study”, BMJ Open, vol. 9, p. e025916, 2019.
, , “Reliability of coded data to identify earliest indications of cognitive decline, cognitive evaluation and Alzheimer's disease diagnosis: a pilot study in England”, BMJ Open, vol. 8, p. e019684, 2018.
, “Thirteen-year trend in the persistence with vitamin K antagonists for venous thromboembolism in the UK: a cohort study”, Curr Med Res Opin, vol. 34, pp. 1985-1990, 2018.
, “Epidemiology of first and recurrent venous thromboembolism in patients with active cancer. A population-based cohort study”, Thromb Haemost, vol. 117, pp. 57-65, 2017.
, “Residual Risk of Stroke and Death in Anticoagulant-Treated Patients With Atrial Fibrillation”, JAMA Cardiol, vol. 1, pp. 366-8, 2016.
, “Risk of recurrent venous thromboembolism after discontinuation of vitamin K antagonist treatment: a nested case-control study”, J Thromb Haemost, vol. 14, pp. 1374-83, 2016.
, “Testosterone treatment and risk of venous thromboembolism: population based case-control study”, Bmj, vol. 355, p. i5968, 2016.
, “Therapy persistence in newly diagnosed non-valvular atrial fibrillation treated with warfarin or NOAC. A cohort study”, Thromb Haemost, vol. 115, pp. 31-9, 2016.
, “Incidence rates of clinically significant tinnitus: 10-year trend from a cohort study in England”, Ear Hear, vol. 36, pp. e69-75, 2015.
, “Increasing incidence of non-valvular atrial fibrillation in the UK from 2001 to 2013”, Heart, vol. 101, pp. 1748-54, 2015.
, “Adverse prognosis of incidentally detected ambulatory atrial fibrillation. A cohort study”, Thromb Haemost, vol. 112, pp. 276-86, 2014.
, “Epidemiology of first and recurrent venous thromboembolism: a population-based cohort study in patients without active cancer”, Thromb Haemost, vol. 112, pp. 255-63, 2014.
, ,
“The freetext matching algorithm: a computer program to extract diagnoses and causes of death from unstructured text in electronic health records”, BMC Med Inform Decis Mak, vol. 12, p. 88, 2012.
, ,
“Prevalence of acute repetitive seizures (ARS) in the United Kingdom”, Epilepsy Res, vol. 87, pp. 137-43, 2009.
, “Preferential prescribing of tibolone and combined estrogen plus progestogen therapy in postmenopausal women”, Menopause, vol. 14, pp. 518-27, 2007.
, “An algorithm to derive a numerical daily dose from unstructured text dosage instructions”, Pharmacoepidemiol Drug Saf, vol. 15, pp. 161-6, 2006.
, ,
“A study of the relation of exposure to quinolones and suicidal behaviour”, Br J Clin Pharmacol, vol. 45, pp. 77-81, 1998.
,